none 10.31254/phyto.2024.13508 BioMed Research Publishers BioMed Research Publishers 16195 169316727 316921 20241224000039714 10.31254 2024-12-24T00:00:46Z 2024-12-24T00:00:41Z 1 The Journal of Phytopharmacology J Phytopharmacol 2320480X 10.31254/phyto https://www.phytopharmajournal.com/ 10 31 2024 13 5 Acharya Balkrishna Hemant Sharma Sakshi Nag Deepika Srivastava Nidhi Sharma Traditional herbal medicinal practices hold profound significance within rural and tribal communities, particularly in addressing prevalent urological diseases. This comprehensive review seeks to elucidate the indigenous knowledge concerning medicinal plants, specifically employed for the treatment of urinary infections. The compilation of data integrates diverse sources, including 'PubMed,' 'PubMed Central,' 'Google Scholar,' and 'Lens.org' publications. The investigation identifies 103 ethnomedicinal plant species distributed across 91 genera and 47 families, acknowledged for their efficacy against urinary and renal ailments in regions such as Jammu and Kashmir, Himachal Pradesh, Uttarakhand, Uttar Pradesh, Rajasthan, and Ladakh. Notably, the Gujjar tribes, among 36 tribes studied, exhibit extensive proficiency in ethnomedicine and botanical knowledge. The systematic presentation of these plant species encompasses their scientific names, local nomenclature, associated tribes, utilized plant parts, modes of administration, and categorized diseases/ailments in a tabulated format. Predominantly utilized medicinal plants for urinary disorders encompass Bergenia ciliata (Haw.) Sternb., B. stracheyi (Hook.f. & Thomson) Engl., Tribulus terrestris L., Malva verticillata L., Chenopodium album L. Selected plant extracts, such as those from Bergenia ciliata, Chenopodium album, Asphodelus tenuifolius, and Betula utilis, have undergone scrutiny for their phytochemical and pharmacological attributes, showcasing promise for novel drug formulations against urological diseases. Ultimately, the findings of this study hold the potential to contribute substantively to the development of evidence-based alternative herbal interventions for urological diseases. 10 31 2024 391 401 1 10.31254/biomed-crossmark-policy www.biomedresearch.org false 10.31254/phyto.2024.13508 https://www.phytopharmajournal.com/assets/pdf_files/Vol13_Issue5_08.pdf